In the US, Xeljanz (tofacitinib systemic) is a member of the drug class antirheumatics and is used to treat Psoriatic Arthritis, Rheumatoid Arthritis and Ulcerative Colitis.
Ingredient matches for Xeljanz
Tofacitinib is reported as an ingredient of Xeljanz in the following countries:
- Hong Kong
Tofacitinib citrate (a derivative of Tofacitinib) is reported as an ingredient of Xeljanz in the following countries:
- South Korea
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.